These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 32807047)
21. Prasanth DSNBK; Murahari M; Chandramohan V; Panda SP; Atmakuri LR; Guntupalli C J Biomol Struct Dyn; 2021 Aug; 39(13):4618-4632. PubMed ID: 32567989 [No Abstract] [Full Text] [Related]
22. Investigation of Some Antiviral Hagar M; Ahmed HA; Aljohani G; Alhaddad OA Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486229 [TBL] [Abstract][Full Text] [Related]
23. Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design. Meyer-Almes FJ Comput Biol Chem; 2020 Oct; 88():107351. PubMed ID: 32769050 [TBL] [Abstract][Full Text] [Related]
24. A threefold approach including quantum chemical, molecular docking and molecular dynamic studies to explore the natural compounds from Centaurea jacea as the potential inhibitors for COVID-19. Muhammad S; Maqbool MF; Al-Sehemi AG; Iqbal A; Khan M; Ullah S; Khan MT Braz J Biol; 2021; 83():e247604. PubMed ID: 34495156 [TBL] [Abstract][Full Text] [Related]
26. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease. Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462 [TBL] [Abstract][Full Text] [Related]
27. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2. Maurya SK; Maurya AK; Mishra N; Siddique HR J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594 [TBL] [Abstract][Full Text] [Related]
28. In silico network pharmacology study on Glycyrrhiza glabra: Analyzing the immune-boosting phytochemical properties of Siddha medicinal plant against COVID-19. Sekaran K; Karthik A; Varghese RP; Sathiyarajeswaran P; Shree Devi MS; Siva R; George Priya Doss C Adv Protein Chem Struct Biol; 2024; 138():233-255. PubMed ID: 38220426 [TBL] [Abstract][Full Text] [Related]
29. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related]
30. Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug. Isgrò C; Sardanelli AM; Palese LL Viruses; 2021 Jan; 13(1):. PubMed ID: 33451132 [TBL] [Abstract][Full Text] [Related]
31. Pharmacoinformatics and hypothetical studies on allicin, curcumin, and gingerol as potential candidates against COVID-19-associated proteases. Oso BJ; Adeoye AO; Olaoye IF J Biomol Struct Dyn; 2022 Jan; 40(1):389-400. PubMed ID: 32876538 [TBL] [Abstract][Full Text] [Related]
32. Molecular docking and machine learning affinity prediction of compounds identified upon softwood bark extraction to the main protease of the SARS-CoV-2 virus. Jablonský M; Štekláč M; Majová V; Gall M; Matúška J; Pitoňák M; Bučinský L Biophys Chem; 2022 Sep; 288():106854. PubMed ID: 35810518 [TBL] [Abstract][Full Text] [Related]
33. Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (M Panikar S; Shoba G; Arun M; Sahayarayan JJ; Usha Raja Nanthini A; Chinnathambi A; Alharbi SA; Nasif O; Kim HJ J Infect Public Health; 2021 May; 14(5):601-610. PubMed ID: 33848890 [TBL] [Abstract][Full Text] [Related]
35. Computational approach investigation bioactive molecules from Saussurea Costus plant as SARS-CoV-2 main protease inhibitors using reverse docking, molecular dynamics simulation, and pharmacokinetic ADMET parameters. Hajji H; Alaqarbeh M; Lakhlifi T; Ajana MA; Alsakhen N; Bouachrine M Comput Biol Med; 2022 Nov; 150():106209. PubMed ID: 36257276 [TBL] [Abstract][Full Text] [Related]
36. Computational and In Vitro Experimental Investigations Reveal Anti-Viral Activity of Licorice and Glycyrrhizin against Severe Acute Respiratory Syndrome Coronavirus 2. Tolah AM; Altayeb LM; Alandijany TA; Dwivedi VD; El-Kafrawy SA; Azhar EI Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959616 [TBL] [Abstract][Full Text] [Related]
37. A Dispersion Corrected DFT Investigation of the Inclusion Complexation of Dexamethasone with β-Cyclodextrin and Molecular Docking Study of Its Potential Activity against COVID-19. Belhocine Y; Rahali S; Allal H; Assaba IM; Ghoniem MG; Ali FAM Molecules; 2021 Dec; 26(24):. PubMed ID: 34946702 [TBL] [Abstract][Full Text] [Related]
38. In-silico efficacy of potential phytomolecules from Ayurvedic herbs as an adjuvant therapy in management of COVID-19. Kumar B; Misra A; Singh SP; Dhar YV; Rawat P; Chattopadhyay D; Barik SK; Srivastava S J Food Drug Anal; 2021 Dec; 29(4):559-580. PubMed ID: 35649148 [TBL] [Abstract][Full Text] [Related]
39. Molecular and structural insights of β-boswellic acid and glycyrrhizic acid as potent SARS-CoV-2 Envelope protein inhibitors. Fatima SW; Alam S; Khare SK Phytomed Plus; 2022 May; 2(2):100241. PubMed ID: 35403092 [TBL] [Abstract][Full Text] [Related]
40. Trypsin is inhibited by phytocompounds liquiritin and terpinen-4-ol from the herb Abhithaj J; Sharanya CS; Arun KG; Jayadevi Variyar E; Sadasivan C J Biomol Struct Dyn; 2024 Apr; 42(6):2957-2964. PubMed ID: 37184119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]